1. Home
  2. TECH vs PEGA Comparison

TECH vs PEGA Comparison

Compare TECH & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • PEGA
  • Stock Information
  • Founded
  • TECH 1976
  • PEGA 1983
  • Country
  • TECH United States
  • PEGA United States
  • Employees
  • TECH N/A
  • PEGA N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • PEGA EDP Services
  • Sector
  • TECH Health Care
  • PEGA Technology
  • Exchange
  • TECH Nasdaq
  • PEGA Nasdaq
  • Market Cap
  • TECH 7.9B
  • PEGA 7.8B
  • IPO Year
  • TECH 1989
  • PEGA 1996
  • Fundamental
  • Price
  • TECH $48.07
  • PEGA $98.59
  • Analyst Decision
  • TECH Buy
  • PEGA Buy
  • Analyst Count
  • TECH 10
  • PEGA 13
  • Target Price
  • TECH $73.44
  • PEGA $100.38
  • AVG Volume (30 Days)
  • TECH 2.3M
  • PEGA 1.0M
  • Earning Date
  • TECH 05-07-2025
  • PEGA 04-22-2025
  • Dividend Yield
  • TECH 0.67%
  • PEGA 0.12%
  • EPS Growth
  • TECH N/A
  • PEGA 156.48
  • EPS
  • TECH 0.83
  • PEGA 2.14
  • Revenue
  • TECH $1,208,770,000.00
  • PEGA $1,642,666,000.00
  • Revenue This Year
  • TECH $8.19
  • PEGA $9.61
  • Revenue Next Year
  • TECH $8.61
  • PEGA $6.09
  • P/E Ratio
  • TECH $57.61
  • PEGA $45.77
  • Revenue Growth
  • TECH 4.72
  • PEGA 14.29
  • 52 Week Low
  • TECH $46.44
  • PEGA $55.71
  • 52 Week High
  • TECH $85.57
  • PEGA $113.67
  • Technical
  • Relative Strength Index (RSI)
  • TECH 39.46
  • PEGA 72.15
  • Support Level
  • TECH $46.77
  • PEGA $92.42
  • Resistance Level
  • TECH $54.40
  • PEGA $99.51
  • Average True Range (ATR)
  • TECH 2.15
  • PEGA 2.27
  • MACD
  • TECH 0.23
  • PEGA 0.45
  • Stochastic Oscillator
  • TECH 8.82
  • PEGA 79.41

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.

Share on Social Networks: